Enose - Derived Response Clusters in Severe Asthmatics Treated With Anti-IL5/5R Biologics

被引：0
|
作者：
Dixey, P. [1 ]
Kermani, N. Zounemat [2 ]
Raby, K. [1 ]
Bhavsar, P. K. [1 ]
Chung, K. [1 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, London, England
[2] Imperial Coll London, Data Sci Inst, London, England
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
基金：
英国医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3013
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A FENO-BASED STRATEGY TO GUIDE ORAL CORTICOSTEROID INITIATION IN PATIENTS WITH SEVERE ASTHMA EXPERIENCING AN EXACERBATION WHILST ON TREATMENT WITH ANTI-IL5/5R THERAPY
    Lam, J. L.
    Hearn, A. P.
    Thomson, L. A.
    Green, L. M.
    Fernandes, M.
    Roxas, C.
    D'Ancona, G.
    Dhariwal, I.
    Nanzer, A. M.
    Jackson, D. J.
    THORAX, 2022, 77 : A87 - A87
  • [32] A comparison of the impact of anti-IL5/5r therapies in allergic versus non-allergic patients with severe eosinophilic asthma in a real-life setting
    Navarro-Cascales, Tatiana
    Colque-Bayona, Monica
    Fernandez-Concha, Ines
    Laorden, Daniel
    Quirce, Santiago
    Dominguez-Ortega, Javier
    JOURNAL OF ASTHMA, 2025, 62 (02) : 319 - 327
  • [33] Late Breaking Abstract- Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE)
    Ali, Nasloon
    Lyu, Juntao
    Newell, Anthony
    Sadatsafavi, Mohsen
    Tran, Trung N.
    Price, David B.
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [34] Anti-IL5 therapy for severe asthma: Towards a MAB war?
    Le Borgne-Krams, A.
    Guilleminault, L.
    Mailhol, C.
    Didier, A.
    REVUE FRANCAISE D ALLERGOLOGIE, 2016, 56 (7-8): : 549 - 555
  • [35] Long-Term Effectiveness of Anti-IL-4R Therapy Following Suboptimal Response to Anti-IL-5/5R Therapy in Severe Eosinophilic Asthma
    Gates, Jessica
    Hearn, Andrew
    Mason, Tom
    Fernandes, Mariana
    Green, Linda
    Thomson, Louise
    Roxas, Cris
    Lam, Jodie
    d'Ancona, Grainne
    Nanzer, Alexandra M.
    Dhariwal, Jaideep
    Jackson, David J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (07): : 1794 - 1800
  • [36] The impact of anti-IL5/5R therapies on reducing exacerbations and systemic corticosteroids in severe asthma: A comparison between allergic versus non-allergic asthmatic patients
    Concha Llona, I. Fernandez
    Colque-Bayona, M.
    Laorden Escudero, D.
    Losantos Garcia, I.
    Navarro Cascales, T.
    Dominguez-Ortega, J.
    ALLERGY, 2023, 78
  • [37] Use of CARAT© to assess anti-IL5/IL-5R impact in united airway disease
    Braganca, M.
    Placido, J. L.
    Amaral, L.
    ALLERGY, 2021, 76 : 172 - 173
  • [38] Are serum immunoglobulins a predictive biomarker of response for anti-IL5 therapies?
    Lauret, Simon
    Guilleminault, Laurent
    Noel-Savina, Elise
    Prevot, Gregoire
    Brouquieres, Danielle
    Didier, Alain
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [39] A case of eosinophilic cystitis successfully treated with anti-IL5 monoclonal antibody
    Bertozzi, I
    Facchini, C.
    Parmigiani, A.
    Cinetto, F.
    Favero, E.
    Agostini, C.
    ALLERGY, 2020, 75 : 337 - 337
  • [40] Anti-IL5 and anti-IL5Rα therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series
    Rademacher, Jessica
    Konwert, Stefanie
    Fuge, Jan
    Dettmer, Sabine
    Welte, Tobias
    Ringshausen, Felix C.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 55 (01)
12345